Merck Analysts Slash Their Forecasts After Q2 Results

Merck & Co Inc MRK reported better-than-expected second-quarter earnings and sales results on Tuesday.The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of$ 15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of$ (2.06), beating the consensus of $2.15.Merck revised and narrowed its full-year 2024 forecasts. The company expects 2024 sales of$ 63.4 billion—$64.4 billi ...